NCS In The News
-
VIKTORIA-1 Trial of Gedatolisib Plus Fulvestrant With or Without Palbociclib in Hormone Receptor–Positive/HER22/ PIK3CA Wild-Type Advanced Breast Cancer
Thursday, March 12, 2026We are pleased to announce the publication of efficacy and safety results from a…
Read more
-
Nebraska Cancer Specialists Named GO2 for Lung Cancer Center of Excellence in Screening and Care
Tuesday, February 10, 2026GO2 for Lung Cancer Recognizes Nebraska Cancer Specialists for Excellence in Early Detection and…
Read more
-
New Year’s Day Black Eyed Peas
Tuesday, December 30, 2025There’s nothing like starting the new year with a little extra luck on your…
Read more
-
💙The Gift of Gratitude
Tuesday, December 23, 2025Reflecting on a Year of Hope and Progress
As the year comes to a close,…
Read more
-
Finding Joy Even When Life Feels Tangled
Monday, December 22, 2025The holidays are often painted as bright, joyful, and perfectly arranged—like strands of lights…
Read more
-
Staying Safe and Healthy in Cold Weather: Tips for Cancer Patients ❄️
Monday, December 15, 2025Winter in Nebraska can be beautiful — but it also brings challenges like cold…
Read more
-
NCS Grantee of ACRO Site Resource Grant
Tuesday, December 9, 2025ACRO’s Site Resource Grants are designed to serve as seed funding to help clinical…
Read more
-
New Study Shows Community Oncology Plays Critical Role in Reducing Cancer-Related Financial Toxicity for Patients
Tuesday, December 2, 2025Peer-reviewed analysis finds community oncology delivers high-quality care at substantially lower costs compared to…
Read more
-
Stefano Tarantolo Medical Journal Articles
Wednesday, November 26, 2025Preliminary Safety, Efficacy and Molecular Characterization in Patients with Higher-Risk Myelodysplastic Syndrome Treated with…
Read more
Purpose • Innovation • Relationship • Excellence
© 2026 Nebraska Cancer Specialists • Privacy Policy • design by Chip Thompson
Meet DOT.
